Skip to main content
. Author manuscript; available in PMC: 2015 Apr 22.
Published in final edited form as: Clin Cancer Res. 2008 May 1;14(9):2710–2716. doi: 10.1158/1078-0432.CCR-07-4636

Table 4.

IHC staining indices of the HER2 pathway markers and percentages of the Ki67-positive cells in the baseline tumors*

PR (N=2)
SD/PD (N=6)
Markers Median Range Median Range
pHER2-Y1248 56.0 54.3–57.7 3.7 0–44.0**
pHER2-Y877 38.8 33.4–44.1 3.3 0–44.5
pMAPK 56.6 42.4–70.8 33.7 12.9–90.1
pAkt 13.5 4.2–22.7 1.6 0–36.8
HER2 64.3 61.6–67.1 74.6 18.7–91.5
Ki67 49.4 37.2–61.6 57.4 18.6–95.3
*

IHC staining index = (staining intensity of a sample – staining intensity of negative control) × percentage of stained cells /100. (30)

**

p-value = 0.095

Percentages of IHC stained cells.

Abbreviations: IHC, immunohistochemistry; PR, partial response; SD, stable disease; PD, progressive disease.